These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9776831)
1. Antihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP. Milewski S; Mignini F; Micossi L; Borowski E Med Mycol; 1998 Jun; 36(3):177-80. PubMed ID: 9776831 [TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP. Milewski S; Mignini F; Covelli I; Borowski E J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618 [TBL] [Abstract][Full Text] [Related]
3. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase. Milewski S; Chmara H; Andruszkiewicz R; Borowski E; Zaremba M; Borowski J Drugs Exp Clin Res; 1988; 14(7):461-5. PubMed ID: 3149235 [TBL] [Abstract][Full Text] [Related]
4. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design. Wojciechowski M; Milewski S; Mazerski J; Borowski E Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase. Milewski S; Andruszkiewicz R; Kasprzak L; Mazerski J; Mignini F; Borowski E Antimicrob Agents Chemother; 1991 Jan; 35(1):36-43. PubMed ID: 1901701 [TBL] [Abstract][Full Text] [Related]
6. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides. Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933 [TBL] [Abstract][Full Text] [Related]
7. The synthesis and biological activity of lipophilic derivatives of bicine conjugated with N³-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP)-an inhibitor of glucosamine-6-phosphate synthase. Koszel D; Lącka I; Kozłowska-Tylingo K; Andruszkiewicz R J Enzyme Inhib Med Chem; 2012 Apr; 27(2):167-73. PubMed ID: 21635214 [TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of thionated analogues of Nva-FMDP and Lys-Nva-FMDP. Nowak-Jary J; Andruszkiewicz R Pol J Microbiol; 2009; 58(4):295-9. PubMed ID: 20380139 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase. Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131 [TBL] [Abstract][Full Text] [Related]
11. A diffusible analogue of N(3)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid with antifungal activity. Zgódka D; Milewski S; Borowski E Microbiology (Reading); 2001 Jul; 147(Pt 7):1955-1959. PubMed ID: 11429472 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of novel ester derivatives of N(3)-(4-metoxyfumaroyl)-(S)-2,3-diaminopropanoic acid containing amide and keto function as inhibitors of glucosamine-6-phosphate synthase. Pawlak D; Schielmann M; Wojciechowski M; Andruszkiewicz R Bioorg Med Chem Lett; 2016 Aug; 26(15):3586-9. PubMed ID: 27324977 [TBL] [Abstract][Full Text] [Related]
13. Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals. Milewski S; Mignini F; Prasad R; Borowski E Antimicrob Agents Chemother; 2001 Jan; 45(1):223-8. PubMed ID: 11120970 [TBL] [Abstract][Full Text] [Related]
14. [Synthesis and anti-Candida albicans properties of L-4-oxalysine-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic-containing peptide analogues]. Feng S; Xu X; Zhang H Yao Xue Xue Bao; 1998 Jun; 33(6):429-35. PubMed ID: 12016912 [TBL] [Abstract][Full Text] [Related]
15. Amide and ester derivatives of N3-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic acid: the selective inhibitor of glucosamine-6-phosphate synthase. Zgódka D; Jedrzejczak R; Milewski S; Borowski E Bioorg Med Chem; 2001 Apr; 9(4):931-8. PubMed ID: 11354676 [TBL] [Abstract][Full Text] [Related]
16. N3-oxoacyl derivatives of L-2,3-diaminopropanoic acid and their peptides; novel inhibitors of glucosamine-6-phosphate synthase. Andruszkiewicz R; Jedrzejczak R; Zieniawa T; Wojciechowski M; Borowski E J Enzyme Inhib; 2000; 15(5):429-41. PubMed ID: 11030083 [TBL] [Abstract][Full Text] [Related]
17. Constrained search of conformational hyperspace of inactivators of glucosamine-6-phosphate synthase. Wojciechowski M; Mazerski J; Borowski E J Enzyme Inhib; 1996; 10(1):17-26. PubMed ID: 8835927 [TBL] [Abstract][Full Text] [Related]
18. Glucosamine-6-phosphate synthase from Escherichia coli: determination of the mechanism of inactivation by N3-fumaroyl-L-2,3-diaminopropionic derivatives. Kucharczyk N; Denisot MA; Le Goffic F; Badet B Biochemistry; 1990 Apr; 29(15):3668-76. PubMed ID: 2111163 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial properties of N3-(iodoacetyl)-L-2,3-diaminopropanoic acid-peptide conjugates. Andruszkiewicz R; Chmara H; Milewski S; Zieniawa T; Borowski E J Med Chem; 1990 Oct; 33(10):2755-9. PubMed ID: 2120441 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the inhibition pathway of glucosamine synthase by N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid by semiempirical quantum mechanical and molecular mechanics methods. Tarnowska M; Oldziej S; Liwo A; Grzonka Z; Borowski E Eur Biophys J; 1992; 21(4):273-80. PubMed ID: 1425480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]